Two-time cancer survivor and Patient Power host, Andrew Schorr, speaks candidly with Dr. Philip Thompson, CLL specialist at MD Anderson Cancer Center. Together, they explore MRD (minimal residual disease) negativity and how this status impacts long-term disease results. Dr. Thompson discusses consolidation strategies that may positively impact 11q and 17p deletion patients as researchers seek answers for a cure.
What Does It Mean to Achieve MRD-Negat... - CLL America Support
What Does It Mean to Achieve MRD-Negative Status?
Written by
mcints
To view profiles and participate in discussions please or .
1 Reply
•
Nice perspective on this measure of treatment efficacy.
Not what you're looking for?
You may also like...
Encouraging Tests on Green Tea Extract
tea-extract-appears-to-keep-cancer-in-check-in-majority-of-cll-patients/
obinutuzumab + venetoclax
remission after treatment….just wish to hear from real patients who have done same treatment to...
